Krystal Biotech
KRYS
KRYS
113 hedge funds and large institutions have $1.11B invested in Krystal Biotech in 2021 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 54 increasing their positions, 30 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
12% less capital invested
Capital invested by funds: $1.27B → $1.11B (-$153M)
56% less call options, than puts
Call options by funds: $3.95M | Put options by funds: $9.03M
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
113
Holding in Top 10
1
Calls
$3.95M
Puts
$9.03M
Top Buyers
| 1 | +$29M | |
| 2 | +$11.7M | |
| 3 | +$9.56M | |
| 4 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
+$7.66M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$4.65M |
Top Sellers
| 1 | -$37.4M | |
| 2 | -$13.2M | |
| 3 | -$10.4M | |
| 4 |
FM
Frazier Management
Seattle,
Washington
|
-$7.28M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$6.75M |